Leiden University
Patent Applications and Registrations
Patent applications and USPTO patent grants for Leiden University.The latest application filed is for "triazole daglalpha inhibitors".
- Leiden University - Leiden NL
- Leiden University - NL NL
- Leiden University - EZ Leiden NL
| Patent | Date |
|---|---|
| Photoactivatable cancer prodrug Grant 10,781,226 - Kornienko , et al. Sept | 2020-09-22 |
| Photoactivatable Cancer Prodrug App 20200239503A1 - | 2020-07-30 |
| Triazole DAGL.alpha. inhibitors Grant 10,583,137 - Cravatt , et al. | 2020-03-10 |
| TRIAZOLE DAGLAlpha INHIBITORS App 20180344729 - CRAVATT; Benjamin F. ; et al. | 2018-12-06 |
| Disease Susceptibility App 20170240967 - de Rijk; Rolandus Hendrikus ; et al. | 2017-08-24 |
| Disease susceptibility Grant 9,644,240 - de Rijk , et al. May 9, 2 | 2017-05-09 |
| Inhibitors of the trypsin-like site of the proteasome and methods of use thereof Grant 8,609,610 - Kisselev , et al. December 17, 2 | 2013-12-17 |
| Inhibitors of the trypsin-like site of the proteasome and methods of use thereof Grant 8,455,431 - Kisselev , et al. June 4, 2 | 2013-06-04 |
| Inhibitors Of The Trypsin-like Site Of The Proteasome And Methods Of Use Thereof App 20130102527 - Kisselev; Alexei F. ; et al. | 2013-04-25 |
| Analogs of nitrobenzylthioinosine Grant 7,781,432 - Ijzermann , et al. August 24, 2 | 2010-08-24 |
| Method Of Detection App 20100143942 - Canters; Gerard W. ; et al. | 2010-06-10 |
| Analogs of nitrobenzylthioinosine Grant 7,358,235 - Puetz , et al. April 15, 2 | 2008-04-15 |
| Isolated peptides derived from MAGE-2, cytolytic T cells specific to complexes of peptide and HLA-A2 molecules, and uses thereof Grant 5,686,068 - Melief , et al. November 11, 1 | 1997-11-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 